Mindblown: a blog about philosophy.
-
HOZO Design Announces Kickstarter Launch of NeoBlade Ultrasonic Cutter on May 13
HOZO Design’s NeoBlade Ultrasonic Cutter is a compact, wireless tool that brings high-frequency cutting technology to evolved makers. HOZO Design, a leader in precision tool innovation, today announced the launch of NeoBlade, a new ultrasonic cutter for the DIY, maker, and 3D printing communities. NeoBlade is a compact, high-efficiency cordless cutter that leverages ultrasonic technology…
-
“Chery+ World” Eco Pavilion is set to grandly open: offering users an immersive tech ecosystem experience
Amidst the dual forces of digital transformation and consumption upgrading, the very definition of modern automobiles is being profoundly reshaped. This mobile carrier equipped with intelligent technology has evolved into the third living space that integrates life aesthetics and digital interaction—it extends not only physical transportation but also the tangible expression of users’ personal identity.…
-
Chery International makes its mark at Auto Shanghai2025, winning global fans with cutting-edge technology
On April 23rd, the grand opening of Auto Shanghai 2025 witnessed Chery International, a leading exporter of automobiles in China, steal the spotlight with an impressive display of 11 exhibit vehicles and numerous groundbreaking technological achievements under its four brands: CHERY, EXEED, OMODA, JAECOO, and iCAUR. It garnered significant attention and favor from nearly 3,000…
-
The Pigment Epithelial Detachment Market is Anticipated to See Significant Growth Across 7MM, Driven by an Aging Population and Innovative Therapies | DelveInsight
retinal pigment epithelium market report DelveInsight The retinal pigment epithelium market is poised for notable growth, fueled by several factors, including an aging population, advancements in AI-driven diagnosis, industry collaborations, and novel therapeutic options. Key retinal pigment epithelium companies include Sumitomo Pharma, Healios K.K., Eyestem Research, Luxa Biotechnology, Regenerative Patch Technologies, Lineage Cell Therapeutics, Katairo…
-
Triple-Negative Breast Cancer Market Projected to Grow at a CAGR of 4.7% by 2035 | DelveInsight
Triple-Negative Breast Cancer Market Report DelveInsight The triple-negative breast cancer treatment market is poised for significant expansion, driven by the introduction of novel targeted therapies, immunotherapeutics, and antibody-drug conjugates by key players such as Merck, Roche, Gilead Sciences, AstraZeneca, Daiichi Sankyo, Seagen, Immunomedics, Novartis, BMS, Pfizer, and Eisai, among others. DelveInsight’s “Triple-Negative Breast Cancer Market…
-
Thymidine Kinase 2 Deficiency Market to Witness Significant Growth by 2034, Driven by Novel Treatment MT1621 | DelveInsight
Thymidine Kinase 2 Deficiency Market Report DelveInsight The Thymidine Kinase 2 deficiency (TK2d) market is poised for substantial growth in the coming decade, fueled by increasing awareness of this rare genetic disorder and the development of promising therapies like MT1621 (UCB). DelveInsight’s “Thymidine Kinase 2 Deficiency Market Insight, Epidemiology and Market Forecast – 2034” report…
-
Myopia Clinical Trials Analysis 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, NICE Approvals, Mechanism of Action, ROA, IND, NDA Approval and Companies by DelveInsight
Myopia Clinical Trials Myopia Companies are Sydnexis, Sunhawk Vision Biotech, Vyluma, Eyenovia, Cloudbreak Therapeutics, Stuart Therapeutics, and others. (Albany, USA) “Myopia Pipeline Insight 2025” report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Myopia Therapeutics Market. As per DelveInsight’s assessment, globally, about 8+ key pharma and…
-
Mantle Cell Lymphoma Clinical Trials Analysis 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, NICE Approvals, Mechanism of Action, ROA, IND, NDA Approval and Companies by DelveInsight
Mantle Cell Lymphoma Clinical Trials Leading mantle cell lymphoma companies are BeiGene, Traws Pharm, Janssen/Pharmacyclics, LegoChem Biosciences, Incyte Corporation, Advenchen Laboratories, Merck & Co, Eternity Bioscience, Adicet Bio, Guangzhou Lupeng Pharmaceutical Company, AbbVie, InnoCare Pharma Inc., TG Therapeutics, Xynomic Pharmaceuticals, Nurix, and others. (Albany, USA) DelveInsight’s, “Mantle Cell Lymphoma Pipeline Insight, 2025,” report provides comprehensive…
-
Retinitis Pigmentosa Drugs Market 2034: EMA, PDMA, FDA Approvals Clinical Trials, Prevalence, Medication, Revenue, Statistics, Pipeline and Companies by DelveInsight
Retinitis Pigmentosa Drugs Market Retinitis Pigmentosa Companies such as Johnson & Johnson Innovative Medicine, MeiraGTx, Beacon Therapeutics, Nanoscope Therapeutics, Gensight Biologics, 4D Molecular Therapeutics, Coave Therapeutics, Ocugen, Bionic Sight, jCyte, Endogena Therapeutics, ProQR Therapeutics, and Aldeyra Therapeutics and others. (Albany, USA) DelveInsight’s “Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast 2034” report delivers an in-depth…
-
Jordan Turnbow is Quietly Redefining What Real Estate Leadership Looks Like
In an industry driven by flash, fast flips, and hype-driven promises, Jordan Turnbow is taking a different path—one built on values, vision, and execution. As co-founder of Automated REI Group, Turnbow isn’t just teaching real estate strategy—he’s rebuilding how leadership in this space should look: focused, mission-driven, and grounded in results. At the core of…
Got any book recommendations?